Ceredex Value Advisors’s Merck MRK Stock Holding History

Ceredex Value Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.4M	Buy	236,353 +23,753	+11%	+$2.78M	0.85%	34
2026 Q1	$25.6M	Sell	212,600 -36,009	-14%	-$4.16M	0.8%	33
2025 Q4	$26.2M	Sell	248,609 -59,123	-19%	-$5.55M	0.79%	35
2025 Q3	$25.8M	Buy	+307,732	New	+$25.3M	0.6%	56
2021 Q1	–	Sell	-658,314	Closed	-$51.8M	–	142
2020 Q4	$51.8M	Sell	658,314 -492,398	-43%	-$37.7M	0.66%	59
2020 Q3	$91.8M	Sell	1,150,712 -226,399	-16%	-$17.7M	1.35%	25
2020 Q2	$102M	Buy	+1,377,111	New	+$104M	1.52%	17

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ceredex Value Advisors's MRK Position: Q2 2026 in Review

Ceredex Value Advisors increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $2.78M and bringing the position to 236,353 shares worth $30.4M. The position accounts for 0.85% of the portfolio, ranked #34.

Ceredex Value Advisors first reported a position in MRK in Q2 2020 and has held it in 7 quarters since. The position peaked at $102M in Q2 2020. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Ceredex Value Advisors held 236,353 shares of Merck worth $30.4M as of Q2 2026.
Ceredex Value Advisors bought 23,753 Merck shares in Q2 2026, an estimated $2.78M.
Merck made up 0.85% of Ceredex Value Advisors's portfolio in Q2 2026, its #34 holding.
Ceredex Value Advisors first reported a position in Merck in Q2 2020 and has held it in 7 quarters since.
Ceredex Value Advisors's Merck position peaked at $102M in Q2 2020.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.